Effects of a Seven-day BASIS™ Supplementation on Menopausal Syndromes and Measurements of the Urinary Vitamin B3 and Estradiol Levels in Pre-, Peri- and Post-menopause
Latest Information Update: 24 Nov 2021
At a glance
- Drugs Nicotinamide-riboside/pterostilbene (Primary)
- Indications Acute kidney injury; Amyotrophic lateral sclerosis; Menopausal syndrome
- Focus Pharmacodynamics
- Sponsors Elysium Health
- 17 Nov 2021 Planned End Date changed from 31 Oct 2021 to 15 Jul 2021.
- 17 Nov 2021 Planned primary completion date changed from 31 Jul 2021 to 15 Jul 2021.
- 16 Apr 2021 New trial record